日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma

非小细胞肺癌患者 ALK 融合的鉴别方法叙述性综述

Susana Hernandez #, Esther Conde #, Marta Alonso, Adrian Illarramendi, Helena Bote de Cabo, Jon Zugazagoitia, Luis Paz-Ares, Fernando Lopez-Rios

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy

FGFR1 和 FGFR4 致癌性依赖于 n-钙粘蛋白,它们的共表达可能预测 FGFR 靶向治疗的疗效

Álvaro Quintanal-Villalonga, Irene Ferrer, Elizabeth Guruceaga, Cristina Cirauqui, Ángela Marrugal, Laura Ojeda, Santiago García, Jon Zugazagoitia, Sandra Muñoz-Galván, Fernando Lopez-Rios, Luis Montuenga, Silvestre Vicent, Sonia Molina-Pinelo, Amancio Carnero, Luis Paz-Ares

SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial

在 III 期 MPACT 试验的探索性分析中,SPARC 表达无法预测白蛋白紫杉醇联合吉西他滨或单独使用吉西他滨治疗转移性胰腺癌的疗效

Manuel Hidalgo, Carlos Plaza, Monica Musteanu, Peter Illei, Carrie B Brachmann, Carla Heise, Daniel Pierce, Pedro P Lopez-Casas, Camino Menendez, Josep Tabernero, Alfredo Romano, Xinyu Wei, Fernando Lopez-Rios, Daniel D Von Hoff